
Alaska federal programs show $3.4M net negative in weekly USAspending rollup
A weekly USAspending.gov program rollup shows net negative dollar adjustments in Alaska for the period June 18 to 25, with two programs accounting for the bulk of the decline and pushing overall activity for the tracked programs below zero.
Two Negative Adjustments Drive the Rollup
Disaster Grants – Public Assistance (Presidentially Declared Disasters) showed a negative adjustment of $2,379,442 during the June 18 to 25 window. Trans-NIH Research Support recorded a separate negative adjustment of $1,049,380 in the same period. Together, the two reductions left net dollar activity across all nine tracked programs at negative $2,547,834, according to USAspending.gov data. The rollup is based on Alaska place of performance and does not identify which specific disaster declaration or Alaska institution is associated with the adjustments. The source data does not establish whether these reflect deobligations, corrections, closeouts, or other accounting changes.
Smaller positive awards did land during the week across seven other programs, including Highway Planning and Construction ($628,100), CDC Investigations and Technical Assistance ($150,000), Injury Prevention and Control Research ($50,000), Indian Self-Determination ($41,200), and Formula Grants for Rural Areas and Tribal Transit ($11,700). Two additional programs, the Health Center Program and Cooperative Agreements to Support State-Based Safe Motherhood and Infant Health Initiative Programs, reported $0 in activity. None of the positive awards came close to offsetting the two large negative figures.
The weekly program rollup is a separate dataset from the statewide federal award snapshot, which as of June 25 showed Alaska holding $11.73 billion in total federal award dollars across 14,322 awards. That figure tracks cumulative prime award dollars for the fiscal year and is not directly affected by week-to-week program-level adjustments.
AI-assisted, reviewed by editors. Spot an error?
Comments
Sign in to leave a comment.
No comments yet. Be the first to share your thoughts.